Dexamethasone treatment of common diabetic eye condition.
NICE is recommending dexamethasone (Ozurdex, Allergan) intravitreal(1) implant, for the treatment of diabetic macular oedema (DMO) in preliminary recommendations published 20/02/ 2015.
The draft guidance recommends dexamethasone as a treatment option in people only where:
- the implant is to be used in an eye with an intraocular (pseudophakic)(2) lens, and
- their diabetic macular oedema does not respond to non-corticosteroid(3) treatment or such a treatment is unsuitable for them.